August 17, 2015 - ASM Comments on Department of State and Commerce Control Regulations for Certain Pathogens
The ASM submitted comments to the US Department of Commerce and the US State Department regarding the Category XIV materials (Toxicological Agents, Including Chemical Agents, Biological Agents, and Associated Equipment) included on the United States Munitions List and the Commerce Control List.
The July issue of the Clinical Microbiology Issues Update has been published by the Office of Public Affairs.
The ASM presented recommendations to the Centers for Medicare & Medicaid Services at its annual public meeting on payment levels for new tests to be included in the 2016 Clinical Laboratory Fee Schedule.
The ASM has been asked to submit comments on the framework for the new National Institutes of Health strategic plan framework.
The Department of Defense (DoD) has requested that we post the following statement to ASM members regarding the inadvertent shipment of anthrax to laboratories.
The Office of Science and Technology Policy (OSTP) is seeking feedback from industry, academia, research laboratories, and other stakeholder groups on both the overarching questions that unite all Microbiome Research.
The Committee on the Status of Women in Microbiology (CSWM) published the Spring issue of their newsletter the CSWM Communicator.
The US Government will hold a meeting for interested stakeholders to discuss implementation of the U.S. Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern on July 22.
The ASM sent comments on the 21st Centurey Cures Initiative to the House Committee on Energy and Commerce.
April 21, 2015 - Energy & Environment Provisions in the America COMPETES Reauthorization Act of 2016
The ASM sent a letter to members of the House Committee on Science, Space and Technology about provisions in the America Competes Reauthorization Act of 2016, H.R. 1806.